JPSIM Journal of Pakistan Society of Internal Medicine J Pak Soc Intern Med 2709-8729 2710-0804 Pakistan Society of Internal Medicine 10.70302/jpsim.v5i4.2472 jpsim.v5i4.2472 Original Research Assessment of Cognitive Functioning in Diabetic Patients with Diabetic Foot Nadeem Hira hiraumar1820@gmail.com * Khan Javed Ahmad Umar Muhammad Nadeem Muhammad Usman Mustafa Muhammad Bilal Asmat Faryal Combined Military Hospital Rawalpinidi Pakistan Navy Station Shifa Hospital Karachi, Fauji Foundation Hospital Rawalpinidi *Correspondence: Hira Nadeem (hiraumar1820@gmail.com) 09 12 2024 2024 5 4 720 722 20 02 2024 31 10 2024 Copyright © 2024 The Author(s) 2024 The Author(s) https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Objective

To determine the prevalence of poor cognitive functioning in diabetics with diabetic foot.

 Methodology

This cross sectional study was undertaken at Combined Military Hospital (CMH) Rawalpindi, from September

to December 2021. The study included 190 patients, known to be diabetic, aged 40 to 70 years of either gender, with

diabetic foot, presenting to Department of medicine CMH Rwp. Patients with advanced kidney disease and dementia were

excluded. Informed consent was taken from all patients. Mini-Mental State investigation (MMSE) results were used to

evaluate overall mental condition (Folstein, Folstein, & McHugh, 1975). Score was noted and if MMSE score was found

24, poor cognitive function was labeled

 Results

The mean age of the patients was 60±7.84 years. In our study, 132(69.47%) were males and 58(30.53%) were

females. The mean duration of disease of the patients was 11.66±4.58 years. 22(11.70%) patients were on oral treatment,

72(38.30%) were on insulin and 94(50%) patients were on both. About 71(37.77%) patients were found to be

hypertensive, and 70(36.8%) patients were smokers. The mean duration of diabetic foot was 2.23±1.93 months and the

mean MMSE score was 23.86±2.95. Poor cognitive functioning was found in 99(52.11%) patients.

 Conclusion

It is concluded that poor cognitive function in diabetic patients with diabetic foot significantly contributes to

the disease.

 Keywords Poor Cognitive Functioning Diabetic Foot diabetes mellitus References Armstrong DG, Boulton AJM, Bus SA. Diabetic Foot Ulcers and Their Recurrence. New England Journal of Medicine. 2017;376(24):2367-75. Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Annals of Medicine. 2017;49(2):106-16. Mishra SC, Chhatbar KC, Kashikar A, Mehndiratta A. Diabetic foot. Bmj. 2017;359:j5064. Amin N, Doupis J. Diabetic foot disease: From the evaluation of the "foot at risk" to the novel diabetic ulcer treatment modalities. World J Diabetes. 2016;7(7):153-64. Khan A, Junaid N. Prevalence of diabetic foot syndrome amongst population with type 2 diabetes in Pakistan in primary care settings. Jpma. 2017;67(1818). J. A. The diabetic foot. Diabetes & Metabolic Syndrome: . Clinical Research & Reviews 01/01/. 2016;10:(01):48-60. Natovich R, Kushnir T, Harman-Boehm I, Margalit D, Siev-Ner I, Tsalichin D, et al. Cognitive dysfunction: part and parcel of the diabetic foot. Diabetes Care. 2016;39(7):1202-7. Ryan C, Vega A, Drash A. Cognitive deficits in adolescents who developed diabetes early in life. Pediatrics. 1985;75(5):921-7. Ryan CM. Diabetes and brain damage: more (or less) than meets the eye? Diabetologia. 2006;49(10):2229-33. Gamal W, Abbas M, Mohamed A. Study of Cognitive Impairment between Diabetic Foot Patients. J Vasc Med Surg. 2018;6(369):2. Kanaya AM, Barrett-Connor E, Gildengorin G, Yaffe K. Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Archives of internal medicine. 2004;164(12):1327-33. Gregg EW, Yaffe K, Cauley JA, Rolka DB, Blackwell TL, Narayan KV, et al. Is diabetes associated with cognitive impairment and cognitive decline among older women? Archives of internal medicine. 2000;160(2):174-80. Van den Berg E, Reijmer Y, De Bresser J, Kessels R, Kappelle L, Biessels G. A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus. Diabetologia. 2010;53(1):58-65. Naguib R, Soliman ES, Neimatallah FM, AlKhudhairy NS, ALGhamdi AM, Almosa RS, et al. Cognitive impairment among patients with diabetes in Saudi Arabia: a cross-sectional study. Middle East Current Psychiatry. 2020;27(1):1-11. Rawlings AM, Sharrett AR, Schneider AL, Coresh J, Albert M, Couper D, et al. Diabetes in midlife and cognitive change over 20 years: a cohort study. Annals of internal medicine. 2014;161(11):785-93. Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes research and clinical practice. 2011;94(3):311-21. Alkhunizan M, Alkhenizan A, Basudan L. Prevalence of mild cognitive impairment and dementia in Saudi Arabia: a community-based study. Dementia and Geriatric Cognitive Disorders Extra. 2018;8(1):98-103. Roy S, Kim N, Desai A, Komaragiri M, Baxi N, Jassil N, et al. Cognitive function and control of type 2 diabetes mellitus in young adults. North American journal of medical sciences. 2015;7(5):220.